期刊文献+

铁载体受体蛋白IroN的原核表达及其对肠道外致病性大肠杆菌感染小鼠的免疫保护作用

Prokaryotic Expression of Recombinant Iron Siderophore Receptor IroN and Immune Protective Effect of Expressed Product against Extraintestinal Pathogenic E.coli Infection in Mice
原文传递
导出
摘要 目的原核表达重组铁载体受体蛋白IroN,并探讨其对小鼠肠道外致病性大肠杆菌群(Extraintestinal pathogenic E.coli,ExPEC)感染的免疫保护作用。方法从E.coliJ96基因组DNA中扩增IroN基因,克隆入原核表达载体pET-32a(+)中,构建原核表达质粒pET-32a-IroN,转化E.coliBL21(DE3),IPTG诱导表达。表达的重组IroN蛋白纯化后,经皮下免疫BALB/c小鼠,采用ELISA法检测小鼠血清和尿液中的抗体水平;以E.coliJ96菌株分别经腹腔和尿道途径攻击免疫小鼠,计算保护率并计数细菌数。结果重组IroN蛋白的表达量为32%,纯化后纯度超过85%,且具有良好的反应原性。重组IroN蛋白经皮下免疫小鼠,可诱导小鼠血清产生高水平的特异性IgG抗体,在尿液中未检测到特异性IgA抗体。重组IroN蛋白对腹腔攻击ExPEC感染小鼠的保护率为81.8%(P<0.05);重组IroN蛋白免疫的小鼠经尿道攻击ExPEC后,肾脏分离的菌落数比对照组(PBS免疫)降低了100倍以上(P<0.05),但膀胱和尿液中的菌落数两组差异无统计学意义(P>0.05)。结论已原核表达并纯化了IroN蛋白,其对ExPEC感染小鼠的腹腔和肾脏具有显著的保护作用,但对膀胱感染无保护作用。 Objective To express recombinant iron siderophore receptor IroN in prokaryotic cells and investigate its protective effect against extraintestinal pathogenic Escherichia coli(ExPEC)infection in mice.Methods IroN gene was amplified from the genomic DNA of E.coli J96 and cloned into prokaryotic expression vector pET-32a(+).The constructed recombinant plasmid pET-32a-IroN was transformed to E.coli BL21(DE3)for expression under induction of IPTG.The expressed recombinant protein was purified and used for immunization of BALB/c mice by subcutaneous route.The antibody levels in sera and urine of immunized mice were determined by ELISA.The immunized mice were challenged with E.coli J96 strain by intraperitoneal and intraurethral routes respectively,based on which the protective rate was calculated,and the bacteria were counted.Results The recombinant IroN protein,at an expression level of 32%,reached a purity of more than 85% after purification and showed good reactogenicity.Subcutaneous immunization with the recombinant IroN protein induced high titer specific IgG in sera of mice,while no specific IgA was detected in urine.The protective rate of recombinant IroN protein against intraperitoneal challenge with ExPEC was 81.8%(P 〈0.05).After intraurethral challenge with ExPEC,the number of bacteria isolated from the kidneys of mice immunized with recombinant IroN protein decreased by more than 100 folds(P 〈0.05),while those in bladder and urine showed no significant difference(P 〉0.05)as compared with those in control groups(immunized with PBS).Conclusions IroN protein was expressed in prokaryotic cells and purified,which showed significantly protective effect against intraperitoneal and renal infection with ExPEC,but showed no protection against bladder infection.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第11期1193-1197,共5页 Chinese Journal of Biologicals
关键词 肠道外致病性大肠杆菌 铁载体受体蛋白 原核细胞 基因表达 免疫保护 Extraintestinal pathogenic Escherichia coli(ExPEC) Iron siderophore receptor protein Prokaryotic cells Gene expression Immune protection
  • 相关文献

参考文献12

  • 1Russo TA, Johnson JR. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC [J]. J Infect Dis, 2000, 181 (5): 1753-1754.
  • 2Lionel D, Arnaud M,Coralie SM, et al. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli [J]. Infect Immun,2007,75:1916-1925.
  • 3Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: "the other bad E coli."[J]. J Lab Clin Med, 2002, 139 (3): 155-162.
  • 4Rubens CS, Denise VM, Lee WR, et al. Identification of uropathogenic Escherichia coli clonal group A(CgA) in hospitalised patients [J]. Mere Inst Oswaldo Cruz, 2009,104(5): 787-789.
  • 5Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections [J]. Ann Intern Med, 2001, 135 (1): 41- 50.
  • 6Bekal S, Brousseau R, Masson L, et ol. Rapid identification of Escherichia coli pathotypes by virulence gene detection with DNA microarrays [J]. J Clin Microbiol, 2003, 41 (5): 2113-2125.
  • 7Bauer RJ, Zhang L, Foxman B, et al. Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN (E. coli)[J]. J Infect Dis, 2002, 185 (10): 1521-1524.
  • 8Russo TA, Carlino UB, Mong A, et al. Identification of genes in an extraintestinal isolate of Escherichia coli with increased expression after exposure to human urine [J]. Infect Immun, 1999, 67 (10): 5306-5314.
  • 9Durant L, Metais A, Soulama-Mouze C, et al. Identification of candidates for a subunit vaccine against extraintestinal pathogenic Escherichia coli [J]. Infect Immun, 2007, 75 (4): 1916-1925.
  • 10Hagan EC, Mobley HL. Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection[J]. Infect hnmun, 2007, 75:3941-3949.

二级参考文献11

  • 1Konadu E, Donohue-Rolfe A, Calderwood SB, et al. Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice. Infect Immun, 1999, 67:6191-6193.
  • 2Dean-Nystrom EA, Gansheroff LJ, Mills M, et al. Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection. Infect Immun, 2002, 70:2414-2418.
  • 3Gansheroff LJ, Wachtel MR, O'Brien AD. Decreased adherence of Enterohemorrhagic Escherichia coli to Hep-2 cells in the presence of antibodies that recognize the C-terminal region of Intimin. Infect Immun, 1999, 67: 6409-6417.
  • 4Sherman PM, Soni R. Adherence of Vero cytotoxin-producing Escherichia coli of serotype O157:H7 to human epithelial cells in tissue culture: role of outer membranes as bacterial adhesins. J Med Microbiol, 1988, 26:11-17.
  • 5Achtman M, Mercer A, Kusecek B, et al. Six Widespread Bacterial Clones Among Escherichia coli K1 Isolates. Infect Immun, 1983, 39:315-335.
  • 6Pascale JM, Shaw MM, Durant PJ, et al. Intranasal immunization confers protection against murine Pneumocysis carinii lung infection. Infect Immun, 1999, 67:805-809.
  • 7Rudin A, Johansson EL, Bergquist C, et al. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of human. Infect Immun, 1998, 66:3390-3396.
  • 8Conlan JW, Cox AD, KuoLee R, et al. Parenteral immunization with a glycoconjugate vaccine containing the O157 antigen of Escherichia coli O157:H7 elicits a systemic humoral immune response in mice, but fails to prevent colonization by the pathogen. Can J
  • 9Michetti P, Mahan MJ, Slauch JM, et al. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimutium. Infect Immun, 1992, 60:1786-1792.
  • 10Phalipon A, Kaufmann M, Michetti P, et al. Monoclonal Immunoglobulin A antibody directed against Serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med, 1995, 182:769-778.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部